A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
Crossref DOI link: https://doi.org/10.1007/s12325-022-02214-1
Published Online: 2022-06-22
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Menzies-Gow, Andrew
Hoyte, Flavia L.
Price, David B.
Cohen, David
Barker, Peter
Kreindler, James
Jison, Maria
Brooks, Christopher L.
Papeleu, Peggy
Katial, Rohit
Text and Data Mining valid from 2022-06-22
Version of Record valid from 2022-06-22
Article History
Received: 20 May 2022
Accepted: 31 May 2022
First Online: 22 June 2022